id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
3009637,e09bcadb-8d8e-4e02-a06a-815b2f44dd7b,Q2,AMERICAN CLINICAL LABORATORY ASSN,1923,AMERICAN CLINICAL LABORATORY ASSN,2023,second_quarter,MMM,"Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, new test coding and pricing, definitive drug testing coding, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); access to clinical laboratory services pursuant to a telehealth visit Saving Access to Laboratory Services Act H.R. 2377/S. 1000,","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,633739,0,0,2023-07-18T11:26:24-04:00